For example, Mysimba (naltrexone/bupropion) has a specific morning and evening dosing schedule and should not simply be moved to the evening, as bupropion can cause insomnia
This measured approach prevents severe nausea and improves long-term adherence
In last years KFF survey, about half the states said they were interested in covering GLP-1s for weight loss, according to Elizabeth Williams, a senior policy manager at KFF who focuses on Medicaid
Research shows improved insulin response and glucose body function, better lipid profiles with reduced triglycerides, enhanced body rate and energy output, improved heart health markers, and better overall body function
GLP-1 receptor agonists like Ozempic and Mounjaro have reshaped the conversation around weight loss and diabetes management
Manufacturers set this 28-day limit based on stability studies conducted under controlled laboratory conditions